Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,119.93
(
0.79%
)
US TECH 100
26,137.40
(
1.41%
)
Dow Jones
49,361.10
(
-0.17%
)
Brent Oil
96.94
(
2.03%
)
Bitcoin
78,826.86
(
3.27%
)
News Focus
News Focus
Post# of 257437
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ciotera

Send PM Follow Ignore
Followers 8
Posts 512
Boards Moderated 0
Alias Born 08/03/2005

ciotera

Re: DewDiligence post# 208083

Tuesday, 01/17/2017 4:10:26 PM

Tuesday, January 17, 2017 4:10:26 PM

Post# of 257437
Re: impetus behind MYSTIC change

They are playing it safe now by pre-specifying an endpoint in PD-L1 positive. This is more likely due to what they saw for Nivolumab+Ipilimumab (CM012) rather than Keytruda+carbo+pem (KN021G)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now